Missed Opportunities in Mother-to-Child HIV Transmission Prevention
Author Information
Author(s): Nkonki Lungiswa L, Doherty Tanya M, Hill Zelee, Chopra Mickey, Schaay Nikki, Kendall Carl
Primary Institution: Health Systems Research Unit, Medical Research Council, Cape Town, South Africa
Hypothesis
Why do many women not receive nevirapine despite high antenatal care attendance?
Conclusion
Strengthening HIV testing and health systems is crucial to reduce missed opportunities in PMTCT interventions.
Supporting Evidence
- 15 out of 58 women missed their nevirapine dose due to health system failures.
- Six women were not tested for HIV during antenatal care.
- Two women received their HIV test results after delivery.
- Seven women tested positive but did not receive nevirapine on time.
Takeaway
Some moms didn't get the medicine to stop passing HIV to their babies because of problems with the health system, not because they didn't want to.
Methodology
In-depth qualitative interviews with 58 HIV-positive women to explore their experiences with antenatal care and PMTCT.
Potential Biases
Potential bias from only including women's views without health provider perspectives.
Limitations
Data was only collected from women's perspectives, which may not capture the full picture of health system failures.
Participant Demographics
Mean age of mothers was 26.3 years; all participants were HIV-positive women who attended antenatal care.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website